0001209191-22-006638.txt : 20220202
0001209191-22-006638.hdr.sgml : 20220202
20220202215803
ACCESSION NUMBER: 0001209191-22-006638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220131
FILED AS OF DATE: 20220202
DATE AS OF CHANGE: 20220202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ranalli Tamara A.
CENTRAL INDEX KEY: 0001822508
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 22586318
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-31
0
0000353569
QUIDEL CORP /DE/
QDEL
0001822508
Ranalli Tamara A.
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
0
1
0
0
SVP, Molecular Bus. Unit
Common Stock
2022-02-01
4
A
0
473
0.00
A
15154
D
Common Stock
2022-02-01
4
F
0
116
102.32
D
15038
D
Non-Qualified Stock Option
103.36
2022-01-31
4
A
0
4957
0.00
A
2032-01-31
Common Stock
4957
4957
D
Restricted Stock Units
2022-01-31
4
A
0
4958
0.00
A
Common Stock
4958
4958
D
Restricted Stock Units
2022-01-31
4
A
0
3386
0.00
A
Common Stock
3386
3386
D
Restricted Stock Units
2022-02-01
4
M
0
473
0.00
D
Common Stock
473
1420
D
Reflects release of restricted stock units that were previously reported on a Form 4.
Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
1,239 shares vest on the first anniversary date of the grant date, January 31, 2023; 1,239 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,239 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,240 shares vest on the fourth anniversary date of the grant date, January 31, 2026.
Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock.
1,239 shares vest on the first anniversary date of the grant date, January 31, 2023; 1,239 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,240 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,240 shares vest on the fourth anniversary date of the grant date, January 31, 2026.
1,693 shares vest on the second anniversary date of the grant date, January 31, 2024; 846 shares vest on the third anniversary date of the grant date, January 31, 2025; and 847 shares vest on the fourth anniversary date of the grant date, January 31, 2026.
One-quarter of the shares subject to the original grant vest annually over a four-year period, commencing on the first anniversary date of the grant date.
Robert J. Bujarski, attorney-in-fact for Tamara A. Ranalli
2022-02-02